|
| |
| | | 54306 | | 27.08.1997 | | GlaxoSmithKline AG | | 25.10.2007 | | | | | | | | | | | 03.04.40. | | | | 03.04.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Axotide 125 | Dosier-Aerosol | () + Metered dose aerosol (Fluticasoni Propionas 125 µg) | R03BA05 | CI | | 02 | Axotide 250 | Dosier-Aerosol | () + Metered dose aerosol (Fluticasoni Propionas 250 µg) | R03BA05 | CI | | 04 | Axotide 50 | Dosier-Aerosol | () + Metered dose aerosol (Fluticasoni Propionas 50 µg) | R03BA05 | CI |
|
|
|
